Confounding control in healthcare database research: challenges and potential approaches
- PMID: 20473199
- PMCID: PMC4024462
- DOI: 10.1097/MLR.0b013e3181dbebe3
Confounding control in healthcare database research: challenges and potential approaches
Abstract
Epidemiologic studies are increasingly used to investigate the safety and effectiveness of medical products and interventions. Appropriate adjustment for confounding in such studies is challenging because exposure is determined by a complex interaction of patient, physician, and healthcare system factors. The challenges of confounding control are particularly acute in studies using healthcare utilization databases where information on many potential confounding factors is lacking and the meaning of variables is often unclear. We discuss advantages and disadvantages of different approaches to confounder control in healthcare databases. In settings where considerable uncertainty surrounds the data or the causal mechanisms underlying the treatment assignment and outcome process, we suggest that researchers report a panel of results under various specifications of statistical models. Such reporting allows the reader to assess the sensitivity of the results to model assumptions that are often not supported by strong subject-matter knowledge.
Similar articles
-
Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature.Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):932-943. doi: 10.1002/pds.5500. Epub 2022 Jul 5. Pharmacoepidemiol Drug Saf. 2022. PMID: 35729705 Free PMC article. Review.
-
Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer.J Clin Epidemiol. 2022 Sep;149:127-136. doi: 10.1016/j.jclinepi.2022.05.021. Epub 2022 Jun 2. J Clin Epidemiol. 2022. PMID: 35662623
-
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.Value Health. 2009 Nov-Dec;12(8):1062-73. doi: 10.1111/j.1524-4733.2009.00602.x. Epub 2009 Sep 29. Value Health. 2009. PMID: 19793071
-
Accounting for uncertainty in confounder and effect modifier selection when estimating average causal effects in generalized linear models.Biometrics. 2015 Sep;71(3):654-65. doi: 10.1111/biom.12315. Epub 2015 Apr 20. Biometrics. 2015. PMID: 25899155 Free PMC article.
-
Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1219-1227. doi: 10.1002/pds.5117. Epub 2020 Sep 14. Pharmacoepidemiol Drug Saf. 2020. PMID: 32929830 Review.
Cited by
-
Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient.J Comp Eff Res. 2015 Jan;4(1):27-35. doi: 10.2217/cer.14.53. J Comp Eff Res. 2015. PMID: 25565067 Free PMC article.
-
Influence of reporting methods of outcomes across transplant centers.Clin J Am Soc Nephrol. 2011 Dec;6(12):2732-4. doi: 10.2215/CJN.11111011. Clin J Am Soc Nephrol. 2011. PMID: 22157704 Free PMC article. No abstract available.
-
Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.Int J Clin Pharm. 2016 Jun;38(3):714-23. doi: 10.1007/s11096-016-0299-0. Epub 2016 Apr 18. Int J Clin Pharm. 2016. PMID: 27091131 Review.
-
Cardiovascular risk profile in individuals initiating treatment for overactive bladder - Challenges and learnings for comparative analysis using linked claims and electronic medical record databases.PLoS One. 2018 Oct 16;13(10):e0205640. doi: 10.1371/journal.pone.0205640. eCollection 2018. PLoS One. 2018. PMID: 30325968 Free PMC article.
-
Employing Bidirectional Two-Sample Mendelian Randomization Analysis to Verify the Potential of Polyunsaturated Fatty Acid Levels in the Prevention of Pancreatic Cancer.Curr Issues Mol Biol. 2024 Jun 14;46(6):6041-6051. doi: 10.3390/cimb46060360. Curr Issues Mol Biol. 2024. PMID: 38921031 Free PMC article.
References
-
- Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58:323–37. - PubMed
-
- Pearl J. Causal diagrams for empirical research. Biometrika. 1995;82:669–88.
-
- Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37–48. - PubMed
-
- Walker AM. Confounding by indication. Epidemiology. 1996;7:335–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources